Cavidi

Russia
Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia, 75450

Company profile

Cavidi company profile

Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of the world’s leading labs. Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses. Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.

Business identity

Contact email
[email protected]
Phone number
46 18 55 20 40
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
1984-01-01, Year

Headquarters

Postal code
75450
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$11.5M
Last funding
Series Unknown / $11.5M / 2018-02-27
Last equity funding
Series Unknown / $11.5M
Investors
1
Lead investors
1
Founders
1
Articles
7

Founders and investors

Founders

Clas Källander

Lead investors

Impilo

Investors

Impilo